Abstract
Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity and Treatment Response in Patients with Progressive and Relapsing Multiple Sclerosis (P1-3.009)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have